We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Repligen Submits IND for Drug to Treat Rare Genetic Defect
Repligen Submits IND for Drug to Treat Rare Genetic Defect
May 13, 2010
Repligen submitted Thursday an IND for a drug to treat a rare genetic defect that causes the body to produce too little of a protein central to healthy nerve function.